
CHS Inc.
CHSCL | NASDAQ
$25.13
+$0.03 (+0.12%)
Sep 22, 2026, 11:21 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Aug 30, 2025 | FY 2024 Aug 30, 2024 | FY 2023 Aug 30, 2023 | FY 2022 Aug 30, 2022 | FY 2021 Aug 30, 2021 | FY 2020 Aug 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 35.46B | 39.26B | 45.59B | 47.79B | 38.45B | 28.41B |
Cost of Revenue | 34.33B | 37.51B | 42.81B | 45.1B | 36.57B | 27.35B |
Gross Profit | 1.14B | 1.75B | 2.78B | 2.69B | 1.88B | 1.05B |
Operating Income | 90.76M | 584.36M | 1.75B | 1.69B | 1.13B | 351.89M |
Interest Income | n/a | n/a | n/a | 114.16M | 104.57M | 116.98M |
Pretax Income | 614.77M | 1.1B | 2.01B | 1.81B | 515.32M | 386.88M |
Net Income | 597.92M | 1.1B | 1.9B | 1.68B | 553.95M | 422.44M |
Selling & General & Admin | 1.05B | 1.15B | 1.03B | 998.41M | 746.71M | 701.56M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 12.46M | n/a | n/a | n/a | n/a |
Operating Expenses | 1.05B | 1.17B | 1.03B | 998.41M | 746.71M | 701.56M |
Interest Expense | 146.08M | 104.06M | 137.44M | 120.26M | 112.57M | 126.65M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 1.11M | -2.99M |
Cost & Expenses | 35.37B | 38.68B | 43.84B | 46.1B | 37.32B | 28.05B |
Income Tax Expense | 16.78M | -4.87M | 107.66M | 132.12M | -38.25M | -36.73M |
Shares Outstanding (Basic) | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Diluted) | n/a | n/a | n/a | n/a | n/a | n/a |
EPS (Basic) | n/a | n/a | n/a | n/a | n/a | n/a |
EPS (Diluted) | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA | 1.41B | 1.68B | 2.61B | 2.39B | 1.08B | 980M |
EBIT | 760.85M | 1.2B | 2.15B | 1.92B | 619.89M | 502.63M |
Depreciation & Amortization | 651.43M | 481.72M | 464.62M | 461.97M | 461.73M | 477.38M |
Add to Watchlist
Select watchlists to add or remove CHSCL